What's in Instituto do Cancer do Estado de São Paulo's pipeline?

Instituto do Cancer do Estado de São Paulo has 3 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Instituto do Cancer do Estado de São Paulo's portfolio?

Top competitors by shared drug class: Henry Ford Health System, Milton S. Hershey Medical Center, Berinstein, Jeffrey, Celgene, Hoffmann-La Roche.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/instituto-do-cancer-do-estado-de-s-o-paulo.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Instituto do Cancer do Estado de São Paulo — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Instituto do Cancer do Estado de São Paulo pipeline: 2 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Local steroid - triamcinolone acetonide	Local steroid - triamcinolone acetonide	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor	Dermatology, Rheumatology, Immunology
Oral steroid - predonisolone	Oral steroid - predonisolone	marketed	Corticosteroid	Glucocorticoid receptor	Oncology, Immunology
Mitomycins	Mitomycins	phase 3			Other

Therapeutic area mix

Dermatology, Rheumatology, Immunology · 1
Oncology, Immunology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Henry Ford Health System · 2 shared drug classes
Milton S. Hershey Medical Center · 2 shared drug classes
Berinstein, Jeffrey · 2 shared drug classes
Celgene · 2 shared drug classes
Hoffmann-La Roche · 2 shared drug classes
Medical University of Lodz · 2 shared drug classes
Assistance Publique - Hôpitaux de Paris · 2 shared drug classes
Sanofi · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Instituto do Cancer do Estado de São Paulo:

Cite this brief

Drug Landscape (2026). Instituto do Cancer do Estado de São Paulo — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/instituto-do-cancer-do-estado-de-s-o-paulo. Accessed 2026-05-18.